Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measuring Central Sensitization and Physical Activity in Adolescents With Hypermobility Spectrum Disorder or Hypermobile Ehlers-Danlos Syndrome

NCT05633225 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT05633225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05633225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measuring Central Sensitization and Physical Activity in Adolescents With Hypermobility Spectrum Disorder or Hypermobile Ehlers-Danlos Syndrome
Lead sponsor
Vastra Gotaland Region
Phase
Observational
Overall status
Completed
Start date
November 25, 2022
Completion date
October 31, 2023
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypermobile ehlers-danlos syndrome, joint hypermobility syndrome